Karthikeyan Kesavan | Pharmacology | Best Researcher Award

Published on by Academic Excellence

Assoc. Prof. Dr. Karthikeyan Kesavan | Pharmacology | Best Researcher Award

Assoc. Prof. Dr. Karthikeyan Kesavan | Pharmacology | Department of Pharmacy, Guru Ghasidas University | India

Dr. Karthikeyan Kesavan is an accomplished academic and researcher serving as an Associate Professor in the Department of Pharmacy at Guru Ghasidas Vishwavidyalaya, Bilaspur. With a Ph.D. in Pharmaceutics from IIT-BHU and postdoctoral research experience at the University of Iowa under the DBT-GETin Fellowship, he has established himself as an expert in nanopharmaceuticals and ocular drug delivery. His research integrates nanotechnology with pharmaceutics to design innovative formulations for treating complex ocular and infectious diseases. Dr. Kesavan has guided Ph.D. and postgraduate scholars, published extensively in high-impact journals, authored influential book chapters, and holds multiple patents in novel drug delivery technologies. His consultancy projects also extend expertise in nanoformulations of natural metabolites for managing ocular diseases. With an H-index of 16 and growing international collaborations, Dr. Kesavan continues to bridge cutting-edge research with practical healthcare applications, contributing significantly to the advancement of pharmacology and pharmaceutical sciences.

Author Profiles

Orcid | Google Scholar

Education 

Dr. Kesavan’s educational journey reflects excellence and dedication to pharmaceutical sciences. He earned his Bachelor of Pharmacy degree, which laid the foundation for his research interests, before pursuing a Master of Pharmacy (M. Pharm) in Pharmaceutics from Bharathidasan University. His academic passion led him to the prestigious Indian Institute of Technology (BHU), Varanasi, where he obtained his Ph.D. in Pharmaceutics, specializing in novel drug delivery systems. To further strengthen his expertise, he completed postdoctoral research at the University of Iowa, USA, under the distinguished DBT-GETin Fellowship, where he gained advanced experience in nanotechnology-based ocular drug delivery. This exposure enhanced his global outlook and scientific rigor, allowing him to integrate diverse approaches into his work. His education uniquely positioned him to contribute to both academic and industry-level pharmaceutical innovations. Today, his academic background continues to influence his impactful research in nanopharmaceuticals, ocular therapeutics, and gene delivery strategies.

Experience

Dr. Kesavan has more than a decade of experience in academia, research, and international collaboration. As an Associate Professor at Guru Ghasidas Vishwavidyalaya, he has played a pivotal role in advancing pharmaceutics education and research. His career includes mentoring doctoral and postgraduate students, designing advanced curricula, and fostering multidisciplinary projects. His consultancy experience extends to developing nanoformulations from medicinal plant metabolites for ocular disease management, bridging academia and applied science. Internationally, his postdoctoral research at the University of Iowa refined his expertise in nanocarrier-mediated gene therapy and non-viral delivery systems. Dr. Kesavan has completed projects funded by UGC, including innovative work on chitosan-coated cationic nanoemulsions for ocular delivery. His professional contributions encompass guiding clinical relevance, managing funded projects, publishing in SCI-indexed journals, authoring influential book chapters, and securing multiple patents. His diverse roles highlight his leadership in pharmacological innovation and his ability to translate research into practical applications.

Awards & Honors 

Throughout his career, Dr. Kesavan has earned significant recognition for his contributions to pharmaceutics and drug delivery research. His selection for the prestigious DBT-GETin Fellowship enabled him to conduct postdoctoral research at the University of Iowa, expanding his international collaborations. He has been awarded UGC-BSR startup grants for innovative work in ocular nanopharmaceuticals, particularly chitosan-coated cationic nanoemulsions. His impactful research has led to multiple patent awards, including recognition for hybrid hydrogel systems and IoT-based health monitoring devices, demonstrating his interdisciplinary innovation. Beyond patents, his publications in high-impact journals and contributions to specialized book chapters highlight his scientific leadership. His role in guiding research scholars and his consultancy services further showcase his dedication to advancing pharmaceutical sciences. These honors not only validate his scientific excellence but also underscore his commitment to pioneering new frontiers in pharmacology and translating research into therapeutic solutions.

Research Focus

Dr. Kesavan’s research focus lies at the intersection of nanotechnology and pharmacology, with a special emphasis on ocular drug delivery systems. His investigations aim to overcome biological barriers by developing innovative nanocarriers, such as nanoemulsions, micelles, and nanocapsules, for improved treatment of eye diseases like glaucoma, uveitis, bacterial keratitis, and fungal infections. His work also explores gene therapy approaches using non-viral vectors for safer and more effective management of ocular disorders. In addition, his patents reflect his expertise in designing mucoadhesive, biocompatible systems that enhance therapeutic efficacy while reducing side effects. Expanding beyond ocular pharmacology, he has also contributed to cancer therapy and infectious disease research through nanocarrier-based formulations. By integrating pharmaceutical sciences with biotechnology and engineering, Dr. Kesavan’s research demonstrates translational value, bridging laboratory discoveries with clinical applications. His focus continues to advance the field of nanopharmaceuticals, ensuring patient-centered, innovative, and sustainable therapeutic solutions.

Publications

    • Healing efficiency of nystatin-loaded chitosan-guar gum-based nanocapsules in experimental fungal keratitis.

    • Tear-Driven Phase Transition Microemulsion for Ocular Delivery of Dexamethasone in Uveitis.

    • Cationic microemulsion of voriconazole for fungal keratitis treatment: in vitro and in vivo evaluation.

    • TPGS-Chitosan Conjugated Mucoadhesive Micelles of Brinzolamide for Glaucoma Therapy.

    • Cationic Chitosan/Pectin Nanocapsules of Moxifloxacin for Bacterial Keratitis Management.

    • Cationic Polyelectrolyte Nanocapsules of Moxifloxacin for Microbial Keratitis Therapy.

    • Phase Transition Microemulsion of Brimonidine Tartrate for Glaucoma Therapy.

    • Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for glaucoma therapy.

    • Positively Charged TPGS-Chitosan Nanocapsules as Non-Viral Vector for Glaucoma Gene Therapy.

    • Topical Ocular Delivery of Nanocarriers: A Feasible Choice for Glaucoma Management.

    • Ocular SMEDDS of Prednisolone for Improved Uveitis Therapy .

    • Tamoxifen citrate loaded chitosan-gellan nanocapsules for breast cancer therapy.

    • Phase Transition W/O Microemulsions for Antibacterial Activity in Bacterial Keratitis.

    • Chitosan-Coated Microemulsions for Enhanced Dermal Clotrimazole Delivery.

Conclusion

Dr. Karthikeyan Kesavan exemplifies excellence in pharmacology through his pioneering research in nanopharmaceuticals, ocular drug delivery, and innovative therapeutic approaches. With a strong educational foundation, impactful teaching experience, and international collaborations, he has established himself as a leader in pharmaceutical research. His extensive publications, patents, and consultancy work highlight his contributions to both academic and industrial advancements. Dr. Kesavan’s dedication to addressing unmet medical needs through nanotechnology-driven solutions continues to shape the future of pharmacology, making him a highly deserving candidate for recognition in the field.

Aruhan | Pharmacology | Best Researcher Award

Published on by Academic Excellence

Dr. Aruhan | Pharmacology | Best Researcher Award

👤  Dr. Aruhan, Jiangxi University of Chinese Medicine, China

Aruhan is a dedicated researcher and scholar at Jiangxi University of Chinese Medicine. Having completed his Bachelor’s and Master’s degrees at Inner Mongolia Minzu University, he is currently pursuing his Doctoral degree in the field of Pharmacology. Aruhan’s research primarily focuses on mental illness, particularly exploring innovative pharmacological solutions for treating mood disorders. His academic journey has been marked by consistent achievements, including multiple academic scholarships and prestigious awards, such as the “Outstanding Student” honor certificate. Aruhan’s work has contributed to the development of new insights into pharmacological treatments, and he continues to expand his academic and research portfolio. His ongoing commitment to understanding mental health and contributing to the scientific community is evident in his recent publication in the Journal of Ethnopharmacology, where he co-authored a study on the potential benefits of Syringa oblata Lindl Extract for alleviating depression.

Professional Profile

orcid

🌟 Suitability for the Research for Best Researcher Award

Aruhan is a promising candidate for the Research for Best Researcher Award due to his academic excellence and commitment to research in the field of mental illness. His educational journey, spanning from a Bachelor’s degree to his ongoing Doctoral studies at Jiangxi University of Chinese Medicine, reflects a consistent dedication to advancing his knowledge.

Though he has not completed ongoing research projects, his work on mental illness, specifically the publication in the Journal of Ethnopharmacology, demonstrates significant potential in the field. This research, titled Syringa oblata Lindl Extract Alleviated Corticosterone-Induced Depression via the cAMP/PKA–CREB–BDNF Pathway, indicates an understanding of complex biochemical pathways involved in depression and offers promising implications for future therapeutic approaches. His first publication is a strong demonstration of his capability, which will likely serve as a foundation for more impactful research in the future.

🎓 Education

Aruhan’s academic journey began with a Bachelor’s degree in Pharmacology from Inner Mongolia Minzu University, where he laid the foundation for his future research endeavors. After completing his undergraduate studies in 2018, he pursued a Master’s degree at the same institution, refining his research focus on pharmacology and mental health. During his Master’s program, Aruhan gained hands-on experience in laboratory research, delving into various pharmacological pathways associated with mental illnesses. This period allowed him to solidify his passion for drug discovery and mental health treatments. Since September 2022, Aruhan has been working towards his Doctoral degree at Jiangxi University of Chinese Medicine. His doctoral research focuses on unraveling the complex mechanisms of mental illness and evaluating the efficacy of medicinal plants. Alongside his academic work, he continues to contribute to the scientific community with several notable publications. Aruhan’s educational background is a testament to his strong commitment to advancing pharmacological research.

💼   Professional Experience

Although Aruhan is in the early stages of his professional career, his academic and research experiences are noteworthy. His work has primarily centered around the pharmacological treatment of mental illnesses. As a doctoral candidate at Jiangxi University of Chinese Medicine, he has contributed to a significant publication in the Journal of Ethnopharmacology on the antidepressant potential of Syringa oblata Lindl Extract. Despite his limited professional experience, Aruhan’s academic performance and involvement in research projects demonstrate his potential to make substantial contributions to the field of pharmacology. In addition to his research, he has actively participated in several academic forums, including the 2022 Conference on Industry-University-Research Cooperation, where he won the third prize for his presentation on the role of pharmacology in mental health. His academic journey is marked by consistent recognition and accolades, positioning him as a promising scholar in pharmacological research and development.

🏅Awards and Recognition 

Aruhan has earned numerous awards throughout his academic career, reflecting his dedication and excellence in his field. Notably, in November 2022, he won the third prize at the “Young Scholars Forum” during the 2022 Conference on Industry-University-Research Cooperation. He was also recognized with multiple academic scholarships, including the second-class general scholarship at Jiangxi University of Chinese Medicine in both 2022 and 2023. Additionally, Aruhan has consistently earned the “Outstanding Student” honor certificate for two consecutive academic years (2022-2023 and 2024-2025), further demonstrating his strong academic standing. His commitment to research excellence and academic achievements culminated in receiving the Lan Shu Excellent Scholarship in 2024. These awards not only reflect his scholastic achievements but also highlight his potential to make meaningful contributions to the field of pharmacology, particularly in mental health research. Aruhan’s passion for advancing science is mirrored in his continual pursuit of academic excellence.

🌍  Research Skills On Pharmacology

Aruhan’s research skills are diverse and robust, allowing him to effectively explore the complexities of mental health and pharmacology. His expertise lies in studying the pharmacological effects of medicinal plants, with a focus on their antidepressant properties. Aruhan is proficient in various research methodologies, including in vivo and in vitro techniques, which enable him to explore the biochemical and molecular mechanisms behind mental illnesses. He is adept at data collection and analysis, using advanced statistical methods to interpret complex research results. His strong laboratory skills are complemented by his ability to synthesize information from a range of academic resources, helping him draw meaningful conclusions in his work. Moreover, Aruhan demonstrates a keen understanding of drug-receptor interactions and the pharmacodynamics of therapeutic agents. His ability to collaborate and communicate findings effectively enhances his research, contributing to his growing reputation within the academic community. Aruhan is committed to continuous learning, ensuring that his research remains relevant and impactful.

📖 Publication Top Notes

Syringa oblata Lindl Extract Alleviated Corticosterone-Induced Depression via the cAMP/PKA–CREB–BDNF Pathway
  • Journal: Journal of Ethnopharmacology
  • Author(s): Ruhan A